European Patent Law Framework Regarding Nanotechnology Applications in Stem Cells
Volume 10, Issue 1
Maryam Ahmadi and Leila Ahmadi
Biotechnology is now being greatly improved by nanotechnology opening new possibilities for research and corresponding inventions. The idea of using nanotechnology to improve patient integration of scaffolding, cell, and grafting procedures has been revolutionary. One particular area which potentially could benefit from this is cell and tissue engineering, including the use of biomedical scaffolds to reduce recovery times and offer new health solutions. Nanotechnology contributes to the development of organs and tissues through of stem cells by providing scaffolds and functionalized surfaces to bring stem cells to do what they are supposed to do.
The combination of nanotechnology and stem cells will dramatically advance our ability to understand and control stem cell-fate decisions and develop novel stem cell technologies, which will eventually lead to stem cell-based therapeutics for the prevention, diagnosis, and treatment of human diseases. These new technologies, like all new fields of technology, are bound to bring new challenges to patent law. This article examines what tissue engineering and stem cells are, the nanotechnology applications in these technologies, the current progress with stem cell research in tissue engineering, and how the existing European patent law framework regarding patentability subject-matter and the ‘order public’ and morality exceptions to patentability can be applied to these new realities.
Full Text (PDF)